Women at risk of breast cancer get access to potentially life-saving drug

A change will be made to the Pharmaceutical Benefits Scheme on Saturday, affecting women most at risk of being diagnosed with breast cancer.

Tamoxifen, which is used to treat women who already have the disease, is already listed.  But now it is listed as a preventative medicine.

Health Minister Sussan Ley said women at risk of breast cancer can now get access to the potentially life-saving drug.


People with diabetes, osteoporosis, high blood pressure and gastric reflux are a few who’ll be better off.

In all over 2000 medicine brands will come down in price.

Savings for non-consessional patients include:

Alendronic acid with colecalciferol up to $23.37

Alendronic acid with colecalciferol and calcium up to $23.37

Cefalotin up to $13.27

Methotrexate up to $10.91

Fosinopril with hydrochlorothiazide up to $10.63

Enalapril with hydrochlorothiazide up to $10.06

Flucloxacillin up to $8.29

For more click here.